Plasma asymmetric and symmetric dimethylarginine in a rat model of endothelial dysfunction induced by acute hyperhomocysteinemia

Amino Acids
Joëlle MagnéFrançois Mariotti

Abstract

Hyperhomocysteinemia induces vascular endothelial dysfunction, an early hallmark of atherogenesis. While higher levels of circulating asymmetric dimethylarginine (ADMA) and symmetric dimethyl arginine (SDMA), endogenous inhibitors of nitric oxide synthesis, have been associated with increased cardiovascular risk, the role that ADMA and SDMA play in the initiation of hyperhomocysteinemia-induced endothelial dysfunction remains still controversial. In the present study, we studied the changes of circulating ADMA and SDMA in a rat model of acutely hyperhomocysteinemia-induced endothelial dysfunction. In healthy rats, endothelium-related vascular reactivity (measured as acetylcholine-induced transient decrease in mean arterial blood pressure), plasma ADMA and SDMA, total plasma homocysteine (tHcy), cysteine and glutathione were measured before and 2, 4 and 6 h after methionine loading or vehicle. mRNA expression of hepatic dimethylarginine dimethylaminohydrolase-1 (DDAH1), a key protein responsible for ADMA metabolism, was measured 6 h after the methionine loading or the vehicle. Expectedly, methionine load induced a sustained increase in tHcy (up to 54.9 ± 1.9 µM) and a 30 % decrease in vascular reactivity compared to the baseline...Continue Reading

References

Dec 10, 1999·Journal of Thrombosis and Thrombolysis·F AndreottiK Robinson
Dec 11, 1999·Arteriosclerosis, Thrombosis, and Vascular Biology·J C ChambersJ S Kooner
Jul 13, 2000·Journal of Chromatography. B, Biomedical Sciences and Applications·D TsikasJ C Frölich
Nov 6, 2003·Scandinavian Journal of Clinical and Laboratory Investigation·P WanbyT Teerlink
Oct 14, 2004·Cleveland Clinic Journal of Medicine·Steven R Lentz, William G Haynes
Jul 7, 2005·Antioxidants & Redox Signaling·Paolo Di SimplicioAnna Di Stefano
Feb 17, 2006·Journal of the American Society of Nephrology : JASN·Stefanie M Bode-BögerHolger Reinecke
Mar 15, 2006·The New England Journal of Medicine·Joseph Loscalzo
May 17, 2006·The Journal of Nutrition·Hieronim Jakubowski
Jul 20, 2006·Annual Review of Nutrition·Michiel P C SiroenPaul A M van Leeuwen
Dec 5, 2006·Current Opinion in Clinical Nutrition and Metabolic Care·John T BrosnanMargaret E Brosnan
Sep 13, 2007·JAMA : the Journal of the American Medical Association·Rex L JamisonUNKNOWN Veterans Affairs Site Investigators
Jun 17, 2008·Arteriosclerosis, Thrombosis, and Vascular Biology·Sanjana Dayal, Steven R Lentz
Jun 24, 2008·American Journal of Physiology. Heart and Circulatory Physiology·Sanjana DayalSteven R Lentz
Sep 3, 2008·Biochemical and Biophysical Research Communications·Nousheen ZaidiHubert Kalbacher
Oct 11, 2008·American Journal of Hypertension·Minjie FengKeith DiPetrillo
May 7, 2009·Nitric Oxide : Biology and Chemistry·Joëlle MagnéFrançois Mariotti
Aug 18, 2009·Pharmacological Research : the Official Journal of the Italian Pharmacological Society·Tom TeerlinkChristopher S Wilcox
Aug 18, 2009·Pharmacological Research : the Official Journal of the Italian Pharmacological Society·Arthur J PopeArturo J Cardounel
May 18, 2011·Molecular Medicine Reports·Takuma ShirakawaAkiyoshi Fukamizu
Jun 7, 2013·Molecular Nutrition & Food Research·Julie LorinLuc Rochette
Sep 7, 2013·Arteriosclerosis, Thrombosis, and Vascular Biology·M Odette GoreRainer H Böger
Sep 10, 2014·Biochemical and Biophysical Research Communications·Faouzia DerouicheMoïse Coëffier

❮ Previous
Next ❯

Related Concepts

Related Feeds

Atherosclerosis Disease Progression

Atherosclerosis is the buildup of plaque on artery walls, causing stenosis which can eventually lead to clinically apparent cardiovascular disease. Find the latest research on atherosclerosis disease progression here.